Sartorius Stedim Biotech opens new Center for Bioprocess Innovation in Marlborough, USA

New research labs and process development services to enable next generation therapeutics

25-Nov-2024 - Sartorius Stedim Biotech opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts. This state-of-the-art facility is designed to foster collaboration, co-development and learning on site with customers and other external innovation partners, applying Sartorius' latest ...

A fungus converts cellulose directly into a novel platform chemical

A new process for the mass production of erythro-isocitric acid from waste could make the substance interesting for industry in the future

27-May-2024 - The fungus Talaromyces verruculosus can produce the chemical erythro-isocitric acid, which has received little attention on the market to date, directly from cheap plant waste and thus make it interesting for industrial utilization. Using the natural abilities of the non-genetically modified ...

Sartorius collaborates with Sanofi to

Commercialization of end-to-end platform for downstream process intensification

20-May-2024 - The life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing. Selected as a preferred supplier, Sartorius will contribute its engineering and manufacturing expertise to ...

Smart MCs Receives Major Australian Government Grant to Establish $600k Advanced Microcarrier Production Line

25-Apr-2023 - Smart MCs has been awarded the Accelerating Commercialisation Grant by the Australian Government to set up an automated microcarrier production line. The grant will allow Smart MCs to meet the rapidly increasing demand for our unique model of microcarriers, which are critical for scalable ...

New solution for stem cell manufacturing

A unique 3D printed system for harvesting stem cells from bioreactors

17-Jun-2022 - Researchers have developed a unique 3D printed system for harvesting stem cells from bioreactors, offering the potential for high quality, wide-scale production of stem cells in Australia at a lower cost. Stem cells offer great promise in the treatment of many diseases and injuries, from ...

Merck Announces Collaboration with Agilent Technologies

Collaboration will help enable real-time release and Bioprocessing 4.0

15-Jun-2022 - Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry is on a ...

Merck Advances BioProcessing Capabilities

Acquisition of MAST® Platform from Lonza, a Automated Bioreactor Sampling System

07-Apr-2022 - Merck will advance its bioprocessing portfolio with the acquisition of the MAST® (Modular Automated Sampling Technology) platform from Lonza. The MAST® platform is an automated, aseptic bioreactor sampling system developed in Bend, Oregon, USA. The financial details of the deal were not ...

Gene therapy start-up VectorY and Wageningen University sign strategic collaboration

Two-part project to develop novel baculovirus genome seeds and bioprocess technologies for the scalable production of AAV gene therapies

27-Jan-2022 - VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, announces a collaboration with Wageningen University to develop novel baculovirus-based ...

Culture Biosciences Raises $80M Series B to Tackle Demand for Large-Scale Biomanufacturing

Culture is closing the gap in manufacturing capacity with its large-scale cloud bioreactors

27-Oct-2021 - Culture Biosciences, a company enabling biotech firms to develop and scale manufacturing processes in the cloud, announced a Series B financing of $80 million led by Northpond Ventures. Synthesis Capital also participated in the round. Existing investors Cultivian Sandbox Ventures, The Production ...

6th BioProScale Symposium 2021 – held virtually for the first time

Online event about the scale-up and scale-down for accelerated bioprocess development and optimization

26-Apr-2021 - From the 29 to 31 March 2021 the 6thBioProScale Symposium was held virtually for the first time. It was organized by the Chair of Bioprocess Engineering at Technische Universität Berlin, the Institute for Fermentation and Biotechnology in Berlin (IfGB) as part of the Versuchs- und Lehranstalt ...